Is low-risk prostate cancer more indolent in younger patients?

Mark Garzotto

doi:10.1200/JCO.2017.72.3684

Is low-risk prostate cancer more indolent in younger patients?

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1870-1871
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	35
Issue number	17
DOIs	https://doi.org/10.1200/JCO.2017.72.3684
State	Published - Jun 10 2017

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2017.72.3684

Cite this

@article{110a46c302a7439b934cba11b1139f4a,

title = "Is low-risk prostate cancer more indolent in younger patients?",

author = "Mark Garzotto",

note = "Funding Information: Merck Sharp & Dohme (Inst), Astellas Medivation (Inst), Genomic Health (Inst), Dendreon (Inst) This work was supported by VA Merit Review from the US Department of Veterans Affairs (Clinical Sciences Research). The content of this manuscript does not necessarily represent the views of the US Department of Veterans Affairs or the US Government.",

year = "2017",

month = jun,

day = "10",

doi = "10.1200/JCO.2017.72.3684",

language = "English (US)",

volume = "35",

pages = "1870--1871",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",